Dr. Rosenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4501 X St
Ste 3016
Sacramento, CA 95817Phone+1 916-734-5981Fax+1 916-734-0631
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
Temple University HospitalResidency, Internal Medicine, 2007 - 2009- Temple University HospitalInternship, Internal Medicine, 2006 - 2007
Icahn School of Medicine at Mount SinaiClass of 2006
Wesleyan UniversityBA, 1997 - 2001
Certifications & Licensure
CA State Medical License 2014 - 2026
MA State Medical License 2010 - 2015
PA State Medical License 2006 - 2010
Clinical Trials
- Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2013 Dec 06
- Ixazomib With Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients With Multiple Myeloma Start of enrollment: 2015 Oct 01
- AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia Start of enrollment: 2016 Jun 13
- Join now to see all
Publications & Presentations
PubMed
- Safety outcomes of teclistamab accelerated dose escalation.Yumena Kawasaki, Aaron Paul Steele, Aaron Rosenberg, Julie Guglielmo
Journal of Oncology Pharmacy Practice. 2024-08-01 - 1 citationsWaldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson Jr, Muhamed Baljevic
Journal of the National Comprehensive Cancer Network. 2024-01-01 - 2 citationsClinical characteristics, treatment patterns, and outcomes among African American and White patients with multiple myeloma in the United States.Ashley Saunders, Samantha Slaff, Krishnaveni Subbiah, Tao Gu, Kwan-Keat Ang
Leukemia & Lymphoma. 2024-01-01
Journal Articles
- Association Between Autologous Stem Cell Transplant and Survival Among Californians with Multiple MyelomaAaron S Rosenberg, Brian A Jonas, Journal of the National Cancer Institute
Abstracts/Posters
- Blinatumomab/Lenalidomide in Relapsed/Refractory Non-HodgkinÍs Lymphoma: A Phase I California Cancer Consortium Study of Safety, Efficacy and Immune Correlative AnalysisAaron Seth Rosenberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Phase I Study of Escalating Doses of Carfilzomib with Hyper-CVAD in Patients with Newly Diagnosed Acute Lymphoblastic Leukemia/LymphomaAaron Seth Rosenberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
